We are live on ! Find out more
DMAC icon

DiaMedica Therapeutics
DMAC

92 hedge funds and large institutions have $96M invested in DiaMedica Therapeutics in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 35 increasing their positions, 18 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 8

94% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 18

41% more call options, than puts

Call options by funds: $314K | Put options by funds: $222K

18% more funds holding

Funds holding: 78 → 92 (+14)

16% more capital invested

Capital invested by funds: $82.8M → $96M (+$13.2M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1.53% less ownership

Funds ownership: 24.68% → 23.15% (-1.5%)

Holders
92
Holders Change
+14
Holders Change %
+17.95%
% of All Funds
1.12%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
22
Increased
35
Reduced
18
Closed
8
Calls
$314K
Puts
$222K
Net Calls
+$92K
Net Calls Change
+$59K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$1.67M
2
State Street
State Street
Massachusetts
+$1.13M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$775K
4
MW
Members Wealth
Pennsylvania
+$758K
5
EI
EAM Investors
California
+$684K

Top Sellers

Rank Fund Capital Flow
1
CLG
Cooperman Leon G
-$9.35M
2
Millennium Management
Millennium Management
New York
-$3.13M
3
Corient Private Wealth
Corient Private Wealth
Florida
-$962K
4
CI
Corient IA
Florida
-$910K
5
First Manhattan
First Manhattan
New York
-$748K
Name Holding Trade Value Shares
Change 		Change in
Stake
Creative Planning
26
Creative Planning
Kansas
$468K +$150K +20,065 +52%
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$453K +$112K +14,958 +36%
SEI Investments
28
SEI Investments
Pennsylvania
$443K +$416K +55,660 New
Barclays
29
Barclays
United Kingdom
$421K +$55.9K +7,471 +16%
MWM
30
Meridian Wealth Management
Kentucky
$403K -$7.67K -1,025 -2%
PCMF
31
Private Capital Management (Florida)
Florida
$398K – – –
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$353K +$120K +16,019 +56%
Wells Fargo
33
Wells Fargo
California
$323K +$140K +18,682 +85%
CFP
34
Catalyst Financial Partners
Massachusetts
$306K – – –
WIA
35
World Investment Advisors
California
$294K +$19.8K +2,650 +8%
AQR Capital Management
36
AQR Capital Management
Connecticut
$285K +$62.2K +8,314 +30%
Marshall Wace
37
Marshall Wace
United Kingdom
$256K -$51.3K -6,862 -18%
TI
38
Trexquant Investment
Connecticut
$246K +$231K +30,954 New
XT
39
XTX Topco
Cayman Islands
$234K +$220K +29,415 New
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$213K -$4.46K -596 -2%
Bank of America
41
Bank of America
North Carolina
$210K +$105K +14,073 +115%
Deutsche Bank
42
Deutsche Bank
Germany
$194K -$62.8K -8,401 -26%
QC
43
Quadrature Capital
United Kingdom
$188K +$176K +23,572 New
Los Angeles Capital Management
44
Los Angeles Capital Management
California
$161K +$172K +22,990 New
T. Rowe Price Associates
45
T. Rowe Price Associates
Maryland
$157K – – –
MIM
46
MetLife Investment Management
New Jersey
$152K +$67.4K +9,018 +90%
Invesco
47
Invesco
Georgia
$148K +$32.1K +4,293 +30%
IIM
48
INTECH Investment Management
Florida
$147K +$33.8K +4,525 +32%
SCA
49
Stonebridge Capital Advisors
Minnesota
$139K – – –
Balyasny Asset Management
50
Balyasny Asset Management
Illinois
$136K +$128K +17,086 New
1
2
3 4

DMAC Hedge Fund Activity: Q4 2025 in Review

92 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in DiaMedica Therapeutics (DMAC) for Q4 2025, worth a combined $96M — up 16% from $82.8M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new DMAC positions and 8 closed out — a net gain of 14 holders — while 35 added to existing stakes and 18 trimmed.

The largest buyer was BlackRock, adding an estimated $1.67M. The largest seller was Cooperman Leon G, cutting an estimated $9.35M.

  • 92 institutional investors held DiaMedica Therapeutics (DMAC) as of Q4 2025, up from 78 in Q3 2025.
  • Funds reported $96M of DiaMedica Therapeutics stock for Q4 2025, up 16% quarter-over-quarter.
  • 22 funds opened new DiaMedica Therapeutics positions in Q4 2025 and 8 closed out, a net change of +14 holders.
  • The largest DiaMedica Therapeutics buyer in Q4 2025 was BlackRock, an estimated $1.67M added.
  • The largest DiaMedica Therapeutics seller in Q4 2025 was Cooperman Leon G, an estimated $9.35M sold.

Based on aggregated 13F filings for Q4 2025.